Literature DB >> 191298

The angiotensin I converting enzyme.

E G Erdös.   

Abstract

The angiotensin I converting enzyme (kininase II; peptidyl dipeptidase; EC3.4.15.1) has a dual function: it converts angiotensin I to angiotensin II and it inactivates bradykinin. Lung, kidney, guinea pig plasma and testicles are among the richest sources of the enzyme. Vascular endothelial cells and bursh borders of renal proximal tubular cells contain high concentrations of the enzyme. The availability of synthetic peptide inhibitors was a great help in establishing the function of converting enzyme in normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191298

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  21 in total

Review 1.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

3.  Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits.

Authors:  W G Campbell; J A Donohue; L H Duket
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 4.  Is reversal of endothelial dysfunction still an attractive target in modern cardiology?

Authors:  Ify Mordi; Nikolaos Tzemos
Journal:  World J Cardiol       Date:  2014-08-26

Review 5.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 6.  Serum angiotensin converting enzyme in pulmonary disease.

Authors:  P K Rohatgi
Journal:  Lung       Date:  1982       Impact factor: 2.584

7.  Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.

Authors:  W G Campbell; J A Donohue; L H Duket
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

8.  Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation.

Authors:  A L Boura; A P Svolmanis
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

9.  Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.

Authors:  A Overlack; K O Stumpe; M Kühnert; R Kolloch; C Ressel; I Heck; F Krück
Journal:  Klin Wochenschr       Date:  1981-01-15

10.  Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo.

Authors:  F A Mendelsohn; C J Lloyd; C Kachel; J W Funder
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.